Top Markets
Coin of the day
Ikonisys S.A. Ikonisys S.A.

Ikonisys S.A.

ALIKO
주식 순위 #28112
Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based... Based in Paris, France, Ikonisys S.A. is a company specializing in cell-based diagnostics. It develops, produces, and commercializes medical diagnostic solutions for various cancers across the United States and Europe. Their core offering includes the Ikoniscope Robotic Microscope, which automates slide manipulation, scanning, and real-time image acquisition and analysis, thereby minimizing human error during diagnostic testing. The company provides a suite of specialized oncoFISH microscopy applications for cancer detection and characterization, such as oncoFISH bladder for analyzing urine samples, oncoFISH her2 for determining HER2 status in breast tissue biopsies, oncoFISH ALK for identifying rearrangements of the ALK gene, and oncoFISH PTEN for detecting PTEN gene deletions in prostate tissue biopsies. Ikonisys also offers tools for characterizing individual circulating tumor cells (CTCs) and analyzing circulating tumor DNA (ctDNA) to provide comprehensive tumor genotype information. Additionally, their Ikonisoft explorer software suite features dedicated FISH scanning applications: Ikonisoft explorer CS for cell suspensions on slides, and Ikonisoft explorer tissue for examining hybridized tissue sections. Finally, the IkoniWAN Gateway provides a secure, validated remote access solution for their Ikoniscope digital microscopy platforms.
주가
$1.80
마지막 동기화: 2026-08-19
시가총액
$28.48M
변동 (1일)
4.11%
변동 (1년)
1.79%
국가
FR
거래 Ikonisys S.A. (ALIKO)

카테고리

Ikonisys S.A. (ALIKO)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Ikonisys S.A.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Ikonisys S.A.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
3.7944 -
US
5.423 -
US
2.0146 -
IE
3.072 -
US
4.9725 -
US